IT8722031A0 - Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina. - Google Patents
Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina.Info
- Publication number
- IT8722031A0 IT8722031A0 IT8722031A IT2203187A IT8722031A0 IT 8722031 A0 IT8722031 A0 IT 8722031A0 IT 8722031 A IT8722031 A IT 8722031A IT 2203187 A IT2203187 A IT 2203187A IT 8722031 A0 IT8722031 A0 IT 8722031A0
- Authority
- IT
- Italy
- Prior art keywords
- calcitonin
- dosage forms
- pharmaceutical formulations
- rectal administration
- rectal
- Prior art date
Links
- 102000055006 Calcitonin Human genes 0.000 title 1
- 108060001064 Calcitonin Proteins 0.000 title 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
- 229960004015 calcitonin Drugs 0.000 title 1
- 239000002552 dosage form Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22031/87A IT1222734B (it) | 1987-09-25 | 1987-09-25 | Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina |
| ES198888114598T ES2037781T3 (es) | 1987-09-25 | 1988-09-07 | Composicion farmaceutica para administracion intrarrectal de una calcitonina y formas de dosificacion unitarias preparadas de estas. |
| DE8888114598T DE3866198D1 (de) | 1987-09-25 | 1988-09-07 | Pharmazeutische zubereitung fuer die intrarektale verabreichung von calcitonin und daraus hergestellte einzeldosisformen. |
| EP88114598A EP0308725B1 (en) | 1987-09-25 | 1988-09-07 | Pharmaceutical composition for intrarectal administration of a calcitonin and unit dosage forms prepared therefrom |
| AT88114598T ATE69384T1 (de) | 1987-09-25 | 1988-09-07 | Pharmazeutische zubereitung fuer die intrarektale verabreichung von calcitonin und daraus hergestellte einzeldosisformen. |
| JP63232750A JPH01102031A (ja) | 1987-09-25 | 1988-09-19 | カルシトニン含有医薬組成物 |
| US07/249,776 US4954342A (en) | 1987-09-25 | 1988-09-26 | Pharmaceutical composition for intrarectal administration of a calcitonin and unit dosage forms prepared therefrom |
| GR920400179T GR3003757T3 (it) | 1987-09-25 | 1992-02-11 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22031/87A IT1222734B (it) | 1987-09-25 | 1987-09-25 | Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8722031A0 true IT8722031A0 (it) | 1987-09-25 |
| IT1222734B IT1222734B (it) | 1990-09-12 |
Family
ID=11190446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT22031/87A IT1222734B (it) | 1987-09-25 | 1987-09-25 | Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4954342A (it) |
| EP (1) | EP0308725B1 (it) |
| JP (1) | JPH01102031A (it) |
| AT (1) | ATE69384T1 (it) |
| DE (1) | DE3866198D1 (it) |
| ES (1) | ES2037781T3 (it) |
| GR (1) | GR3003757T3 (it) |
| IT (1) | IT1222734B (it) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH657779A5 (de) * | 1982-10-05 | 1986-09-30 | Sandoz Ag | Galenische zusammensetzungen enthaltend calcitonin. |
| HU203204B (en) * | 1987-09-15 | 1991-06-28 | Sandoz Ag | Process for producing suppository containing calcitonin and taurocholic acid |
| JP2514249B2 (ja) * | 1989-05-23 | 1996-07-10 | 帝人株式会社 | 安定化されたカルシトニン類医薬組成物 |
| IT1237197B (it) * | 1989-11-16 | 1993-05-26 | Sclavo Spa | Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina. |
| IT8922398A0 (it) * | 1989-11-16 | 1989-11-16 | Phidea Spa | Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva. |
| SE9101381D0 (sv) * | 1991-05-07 | 1991-05-07 | Tomas Moks | Peptide hormone solution |
| US5904935A (en) * | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
| US5726154A (en) * | 1996-06-28 | 1998-03-10 | University Of Utah Research Foundation | Stabilization and oral delivery of calcitonin |
| WO2005037108A2 (en) * | 2003-10-21 | 2005-04-28 | Ramot At Tel Aviv University Ltd. | Compositions and devices including same useful for anastomosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4151276A (en) * | 1975-05-12 | 1979-04-24 | Armour Pharmaceutical Company | Method of suppressing gastric acid secretion by the oral administration of calcitonin |
| US4067960A (en) * | 1975-06-20 | 1978-01-10 | R. P. Scherer Limited | Pharmaceutical compositions containing cardiac glycoside |
| EP0037943B1 (en) * | 1980-03-31 | 1985-08-14 | Teijin Limited | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
| US4618598A (en) * | 1982-04-12 | 1986-10-21 | Duke University | Method of regulating hormone function or release |
| DE3307353C2 (de) * | 1983-03-02 | 1985-01-31 | R.P. Scherer GmbH, 6930 Eberbach | Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| US4486412A (en) * | 1983-03-15 | 1984-12-04 | Pharmacaps, Inc. | Encapsulated antacid dispersions |
| US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
-
1987
- 1987-09-25 IT IT22031/87A patent/IT1222734B/it active
-
1988
- 1988-09-07 AT AT88114598T patent/ATE69384T1/de active
- 1988-09-07 DE DE8888114598T patent/DE3866198D1/de not_active Expired - Fee Related
- 1988-09-07 EP EP88114598A patent/EP0308725B1/en not_active Expired - Lifetime
- 1988-09-07 ES ES198888114598T patent/ES2037781T3/es not_active Expired - Lifetime
- 1988-09-19 JP JP63232750A patent/JPH01102031A/ja active Pending
- 1988-09-26 US US07/249,776 patent/US4954342A/en not_active Expired - Fee Related
-
1992
- 1992-02-11 GR GR920400179T patent/GR3003757T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2037781T3 (es) | 1993-07-01 |
| US4954342A (en) | 1990-09-04 |
| IT1222734B (it) | 1990-09-12 |
| DE3866198D1 (de) | 1991-12-19 |
| EP0308725A3 (en) | 1989-04-26 |
| EP0308725B1 (en) | 1991-11-13 |
| GR3003757T3 (it) | 1993-03-16 |
| JPH01102031A (ja) | 1989-04-19 |
| EP0308725A2 (en) | 1989-03-29 |
| ATE69384T1 (de) | 1991-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8622683A0 (it) | Dispositivo terapeutico per la somministrazione di medicamenti. | |
| IT8267184A0 (it) | Bendaggio per la somministrazione di medicamenti | |
| NO863029D0 (no) | Farmasoeytisk doseringsenhet. | |
| IT8423263A0 (it) | Formulazioni farmaceutiche acquose di piroxicam monoidrato. | |
| NL190923C (nl) | Farmaceutisch preparaat omvattende ibuprofen en caffeine. | |
| DE3682083D1 (de) | Pharmazeutische zusammensetzungen. | |
| IT9019112A1 (it) | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina | |
| IT8622844A0 (it) | Formulazioni farmaceutiche acquose di ubichinone. | |
| IT8722031A0 (it) | Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina. | |
| DE3674040D1 (de) | Pharmazeutische zusammensetzungen. | |
| IT8521322A0 (it) | Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche. | |
| IT8722501A0 (it) | Formulazioni farmaceutiche per somministrazione transdermica. | |
| IT8619382A0 (it) | Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale. | |
| IT8722647A0 (it) | Composizione farmaceutica per somministrazione nasale. | |
| IT1237197B (it) | Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina. | |
| NL193441B (nl) | Farmaceutisch preparaat voor veterinair gebruik. | |
| DE3871159D1 (de) | Pharmazeutische und tieraerztliche zusammensetzungen. | |
| IT8520591A0 (it) | Formulazione farmaceutica. | |
| IT8520712A0 (it) | Formulazioni farmaceutiche per stimolare la liberazione di ormone somatotropo. | |
| IT8820618A0 (it) | Forma farmaceutica e supporto per la somministrazione di estratti ellergenici. | |
| DE69001540D1 (de) | Arzneimittel zur rektalen verabreichung von calcitonin. | |
| FR2577800B1 (fr) | Medicament sous forme galenique gastro-resistante | |
| NL185666C (nl) | Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen. | |
| DE3667915D1 (de) | Pharmazeutische zusammensetzung. | |
| IT8224219A0 (it) | Composizione farmaceutica per la somministrazione orale di calcitonina. |